Clinical Trial

Vasopressor Agents in Pulmonary Hypertension Crisis

Name: Vasopressor Agents in Pulmonary Hypertension Crisis — clinical trial record (NCT07667829)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Comparison of the efficacy and safety of three vasoactive agents-dopamine, norepinephrine, and epinephrine-in the treatment of patients with pulmonary hypertension crisis: prospective, randomised controlled trial monitored by haemodynamic monitoring

Trial Details

NCT Number	NCT07667829
Lead Sponsor	China National Center for Cardiovascular Diseases
Conditions	Pulmonary Arterial Hypertension (PAH), Chronic Thromboembolic Pulmonary Hypertension (CTEPH), Hypertension, Pulmonary
Enrollment	75 participants
Start Date	2026-06
Primary Completion	2028-12-31 (estimated)
Study Completion	2029-01-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-25